Michel Ovize

5PUBLICATIONS
38CO-AUTHORS
Molecular targetsNumerical modelling and mechanical characterisationCardiology (incl. cardiovascular diseases)PharmacogenomicsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 10, 2026
A randomized first-in-human study of a novel growth hormone receptor peptide antagonist ALXN2420 in healthy subjects.

|Mar 16, 2026
Ischaemia-reperfusion dynamics in acute myocardial infarction experimental swine model: new insights from quantitative CMR.

Magalie Viallon, Lorena Petrusca, Nicolas Duchateau

|Jul 23, 2025
Bone status in patients with chronic hypoparathyroidism: results from the Italian HypoparaNET database.

Francesca Marini, Francesca Giusti, Blandine Weiss

|May 27, 2025
Phase 1 clinical trial of eneboparatide, a novel PTH receptor 1 agonist.

Michel Ovize, Soraya Allas, Michael D Culler

|Mar 07, 2024
An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism.

Istvan Takacs, Emese Mezosi, Alfonso Soto

Pageof 1

Frequent Collaborators

2 joint publications

Mark Sumeray

1 joint publications

Istvan Takacs

1 joint publications

Emese Mezosi

1 joint publications

Alfonso Soto